BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10396040)

  • 1. Role of complement receptors CD21/CD35 in B lymphocyte activation and survival.
    Carroll M
    Curr Top Microbiol Immunol; 1999; 246():63-8; discussion 69. PubMed ID: 10396040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of humoral immune responses by CD21/CD35.
    Chen Z; Koralov SB; Kelsoe G
    Immunol Rev; 2000 Aug; 176():194-204. PubMed ID: 11043778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling CD21 and CD19 of the B-cell coreceptor.
    Barrington RA; Schneider TJ; Pitcher LA; Mempel TR; Ma M; Barteneva NS; Carroll MC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14490-5. PubMed ID: 19706534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement in B cell activation and tolerance.
    Carroll MC
    Adv Immunol; 2000; 74():61-88. PubMed ID: 10605604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
    Rickert RC
    Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation.
    Gommerman JL; Oh DY; Zhou X; Tedder TF; Maurer M; Galli SJ; Carroll MC
    J Immunol; 2000 Dec; 165(12):6915-21. PubMed ID: 11120817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
    Molina H; Holers VM; Li B; Fung Y; Mariathasan S; Goellner J; Strauss-Schoenberger J; Karr RW; Chaplin DD
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3357-61. PubMed ID: 8622941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of germinal center B cells on expression of CD21/CD35 for survival.
    Fischer MB; Goerg S; Shen L; Prodeus AP; Goodnow CC; Kelsoe G; Carroll MC
    Science; 1998 Apr; 280(5363):582-5. PubMed ID: 9554848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.
    Ogembo JG; Kannan L; Ghiran I; Nicholson-Weller A; Finberg RW; Tsokos GC; Fingeroth JD
    Cell Rep; 2013 Feb; 3(2):371-85. PubMed ID: 23416052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement and complement receptors in induction and regulation of immunity.
    Carroll MC
    Annu Rev Immunol; 1998; 16():545-68. PubMed ID: 9597141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.
    Zabel MD; Heikenwalder M; Prinz M; Arrighi I; Schwarz P; Kranich J; von Teichman A; Haas KM; Zeller N; Tedder TF; Weis JH; Aguzzi A
    J Immunol; 2007 Nov; 179(9):6144-52. PubMed ID: 17947689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD21 signaling via C3 regulates Purkinje cell protein 4 expression.
    Jacobson AC; Weis JJ; Weis JH
    Mol Immunol; 2009 Apr; 46(7):1488-93. PubMed ID: 19201479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle.
    Pringle ES; Firth MA; Chattha KS; Hodgins DC; Shewen PE
    Dev Comp Immunol; 2012 Dec; 38(4):487-94. PubMed ID: 22989997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35.
    Rossbacher J; Haberman AM; Neschen S; Khalil A; Shlomchik MJ
    Eur J Immunol; 2006 Sep; 36(9):2384-93. PubMed ID: 16906534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.